ONE-WAYOngoing theme · still written in the latest filings
Indication Selection Based on Nonclinical Data and the Rapid, Reliable Advancement of Clinical Development
A development execution policy that selects indications based on nonclinical study data and advances clinical trials reliably and rapidly through both in-house development and co-development with partners.
Companies3How many companies write about this.
Threads3One company can carry more than one thread here.